Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector
Clinical trial NCT02022696 · COMPLETED
Trial details
- NCT number
- NCT02022696
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-16
- Primary completion
- 2013-12-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.